Cost Curve

China Could Be the Big Winner of Trump’s Push to Boost Drug Prices in Europe

And in Alaska, issues around drug pricing are barely registering in the tussle for the Senate

Brian Reid

Epic Pledges to Make It Simple for Docs to See Cash-Pay Prices From Costco, Lilly, Cuban, and More

And our election monitor stops in Maine today, where Medicare-for-all is a focus

Brian Reid

The Cost Curve Campaign Trail Begins in Texas, With Insulin, ‘Big Pharma,’ and PBMs

Brian Reid

Cost Curve Prepares to Dive Into the Pharma Implications of This Year’s Biggest Races

And new inflation data shows a historic drop in drug prices, but you shouldn’t put too much stock in those numbers

Brian Reid

Hospitals Again Sue to Stop 340B Rebate Models, Setting Up a Re-Do of Last Year’s Legal Battle

And I regret to inform you that Martin Shkreli is once more generating headlines

Brian Reid

Should a Lack of Pharmaceutical Reform Alliance Disclosure Erode Confidence in the Research It Sponsors?

Brian Reid

PhRMA Suit to Stop MFN Prices in Medicare Has Broader Implications

And HHS data shows the impact of restricting Medicare spending on 340B drugs

Brian Reid

The Pharmaceutical Reform Alliance’s Backing Remains a Mystery, Even To Its Supporters

Brian Reid

KFF Poll Finds 36% of Americans Support Burning the U.S. Healthcare System to the Ground

And a PBM-linked Pharmaceutical Reform Alliance member with a questionable understanding of the PBM industry

Brian Reid